Adam S. Mostafa - Mar 1, 2022 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Signature
Derek M. Meisner-attorney-in-fact
Stock symbol
XFOR
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/1/2022, 03:09 PM
Previous filing
Feb 14, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Award $0 +105K +112.63% $0.00 198K Mar 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in two equal annual installments on March 1, 2023 and March 1, 2024, subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.
F2 Represents unvested restricted stock units.